Universe Pharmaceuticals (UPC) Retained Earnings (2020 - 2026)
Universe Pharmaceuticals (UPC) posted Retained Earnings of -$15.4 million for Q1 2026, down 11.23% sequentially from -$13.8 million in Q3 2025.
Universe Pharmaceuticals (UPC) Retained Earnings (2020 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Retained Earnings for 7 years, with the latest figure at -$15.4 million in Q1 2026.
- Quarterly Retained Earnings changed N/A year-over-year to -$15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.4 million (changed N/A YoY) and the FY2025 annual result came in at -$13.8 million, up 99.86% from the prior year.
- Retained Earnings slipped to -$15.4 million in Q1 2026 per UPC's latest filing, from -$13.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at $26.8 million in Q1 2022 and troughed at -$10.2 billion in Q3 2024.
- A 5-year average of -$1.3 billion and a median of -$2.2 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 428674.83% in 2024, then soared 99.86% in 2025.
- Over 5 years, Retained Earnings stood at $16.3 million in 2022, then sank by 114.53% to -$2.4 million in 2023, then slumped by 428674.83% to -$10.2 billion in 2024, then jumped by 99.86% to -$13.8 million in 2025, then slipped by 11.23% to -$15.4 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$15.4 million, -$13.8 million, and -$10.2 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.03 Bn | 43.06 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.97 Bn | 39.31 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.63 Bn | 29.95 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.54 Bn | 22.74 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.68 Bn | 17.80 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - | 3.75 Bn |
| 10 | Universe Pharmaceuticals | 2.92 Mn | -26.13 Mn | - | -15.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.40 Mn |
| Sep 30, 2025 | -13.84 Mn |
| Sep 30, 2024 | -10.17 Bn |
| Mar 31, 2024 | -2.10 Mn |
| Sep 30, 2023 | -2.37 Mn |
| Mar 31, 2023 | -266,930.00 |
| Sep 30, 2022 | 16.32 Mn |
| Mar 31, 2022 | 26.79 Mn |
| Sep 30, 2021 | 29.28 Mn |
| Sep 30, 2020 | 13,738.98 Bn |